0

    544482

    STARIMAGIN

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Star Imaging And Path Lab Limi Share Price Today

    Investment Returns

    Over 1 Month 40.85% Over 3 Months 94.44% Over 6 Months 12.98% Over 1 Year -24.88%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Star Imaging And Path Lab Limi fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 175.10
    • P/E Ratio (TTM) 9.02
    • Beta 1.64
    • Book Value / share 66.61
    • Return on equity 40.62%
    • EPS (TTM) 11.09
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.00
    info icon alternate text

    Star Imaging And Path Lab Limi Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 88.53
    Operating Expense 63.21
    Net Profit 19.32
    Net Profit Margin (%) 21.82
    Earnings Per Share (EPS) 11.09
    EBITDA 34.22
    Effective Tax Rate (%) 26.59
    Particulars MAR 2025 (Values in Cr)
    Revenue 83.24
    Operating Expense 62.19
    Net Profit 15.91
    Net Profit Margin (%) 19.11
    Earnings Per Share (EPS) 11.79
    EBITDA 28.79
    Effective Tax Rate (%) 25.41
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 34.93
    ROE % 40.66
    ROCE % 34.39
    Total Debt to Total Equity 0.81
    EBITDA Margin 35.47
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 209.01
    ROE % 49.52
    ROCE % 35.09
    Total Debt to Total Equity 1.14
    EBITDA Margin 30.95
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 126.23
    ROE % 3.11
    ROCE % 6.03
    Total Debt to Total Equity 1.50
    EBITDA Margin 10.59
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 122.37
    ROE % 34.26
    ROCE % 23.33
    Total Debt to Total Equity 1.61
    EBITDA Margin 21.51
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 34.86
    ROE % 40.62
    ROCE % 33.32
    Total Debt to Total Equity 0.81
    EBITDA Margin 34.65
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 208.46
    ROE % 49.16
    ROCE % 33.89
    Total Debt to Total Equity 1.14
    EBITDA Margin 30.20
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 126.21
    ROE % 3.06
    ROCE % 5.97
    Total Debt to Total Equity 1.50
    EBITDA Margin 10.59
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 122.38
    ROE % 34.31
    ROCE % 23.33
    Total Debt to Total Equity 1.61
    EBITDA Margin 21.54
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 5.34
    Total Assets 98.15
    Total Liabilities 98.15
    Total Equity 47.23
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 16.22
    Return on Capital (%) 19.92
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 15.71
    Total Assets 81.63
    Total Liabilities 81.63
    Total Equity 31.40
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 15.21
    Return on Capital (%) 20.02
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 2.35
    Total Assets 61.23
    Total Liabilities 61.23
    Total Equity 18.94
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 0.94
    Return on Capital (%) 1.27
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 9.04
    Total Assets 58.34
    Total Liabilities 58.34
    Total Equity 18.36
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 10.78
    Return on Capital (%) 13.13
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 5.14
    Total Assets 97.89
    Total Liabilities 97.89
    Total Equity 47.05
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 16.25
    Return on Capital (%) 19.94
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 15.44
    Total Assets 81.31
    Total Liabilities 81.31
    Total Equity 31.26
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 15.17
    Return on Capital (%) 19.93
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 2.17
    Total Assets 61.02
    Total Liabilities 61.02
    Total Equity 18.93
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 0.93
    Return on Capital (%) 1.26
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 8.97
    Total Assets 58.27
    Total Liabilities 58.27
    Total Equity 18.35
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 10.81
    Return on Capital (%) 13.16
    Particulars MAR 2025 (Values in Cr)
    Net Income 21.43
    Cash from Operations -0.58
    Cash from Investing -3.96
    Cash from Financing -0.37
    Net change in Cash -10.36
    Free Cash Flow 3.63
    Particulars MAR 2024 (Values in Cr)
    Net Income 16.11
    Cash from Operations 22.13
    Cash from Investing -6.86
    Cash from Financing 1.88
    Net change in Cash 13.36
    Free Cash Flow 30.57
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.88
    Cash from Operations 5.74
    Cash from Investing -7.22
    Cash from Financing -4.74
    Net change in Cash -6.69
    Free Cash Flow 13.04
    Particulars MAR 2022 (Values in Cr)
    Net Income 9.38
    Cash from Operations 17.46
    Cash from Investing -4.14
    Cash from Financing -6.98
    Net change in Cash 3.27
    Free Cash Flow 21.74
    Particulars MAR 2025 (Values in Cr)
    Net Income 21.33
    Cash from Operations -0.57
    Cash from Investing -3.96
    Cash from Financing -0.37
    Net change in Cash -10.30
    Free Cash Flow 3.64
    Particulars MAR 2024 (Values in Cr)
    Net Income 16.00
    Cash from Operations 22.03
    Cash from Investing -6.86
    Cash from Financing 1.88
    Net change in Cash 13.26
    Free Cash Flow 30.48
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.87
    Cash from Operations 6.93
    Cash from Investing -8.56
    Cash from Financing -4.69
    Net change in Cash -6.79
    Free Cash Flow 15.58
    Particulars MAR 2022 (Values in Cr)
    Net Income 9.39
    Cash from Operations 16.92
    Cash from Investing -4.13
    Cash from Financing -6.99
    Net change in Cash 3.26
    Free Cash Flow 21.19
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8616.80 63.34 13.07 123896.36 6680.00 8758.00
    FORTIS MALAR HOSPITALS LIMITED 51.78 23.43 2.82 97.04 40.75 76.00
    SHREE PACETRONIX LTD. 131.30 15.67 2.76 49.23 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.02 0.00 2.73 22.88 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8616.80 82.53 12.43 123896.36 6680.00 8758.00
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 40.00 0.00 -9.73 29.88 30.30 57.48
    KOVAI MEDICAL CENTER & HO 6049.40 27.07 5.01 6618.04 5010.00 6725.00

    Star Imaging And Path Lab Limi shareholding pattern

    Holding
    21.33%
    71.91%
    0.6%
    6.14%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Star Imaging And Path Lab Limi Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    100.50 0.50 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 96.40
    • 26 Days 85.20
    • 10 Days 91.90
    • 50 Days 80.80
    • 12 Days 90.70
    • 100 Days 81.90
    • 20 Days 87.10
    • 200 Days 97.30
    100.75 PIVOT
    First Support 98.49 First Resistance 104.37 Second Support 94.87 Second Resistance 106.63 Third Support 92.61 Third Resistance 110.25
    RSI 75.72 ADX 27.24 MACD 4.93 Williams % R -3.38 Commodity Channel Index (CCI) 227.46
    Date 2026-07-01 Week 59600.00 Same Day 64000.00 Month 29500.00
    1 Year 1.64 3 Year 1.65
    Over 1 Month
    40.85% down
    Over 1 Year
    -24.88% down
    Over 3 Months
    94.44% down
    Over 3 Years
    0.00% down
    Over 6 Months
    12.98% down
    Over 5 Years
    0.00% down

    Star Imaging And Path Lab Limi Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Star Imaging and Path Lab Ltd?

    Answer Field

    Star Imaging and Path Lab Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 100.50 as on Jul 03 2026 01:10 PM.

    What is the Market Cap of Star Imaging and Path Lab Ltd Share?

    Answer Field

    The market cap of Star Imaging and Path Lab Ltd for NSE ₹ 0.00 & for BSE ₹ 175.10 as on Jul 03 2026 01:10 PM.

    What is the 52 Week High and Low of Star Imaging and Path Lab Ltd?

    Answer Field

    The 52 Week High and Low of Star Imaging and Path Lab Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 152.00 and ₹ 46.00.

    What is 1 year return for Star Imaging and Path Lab Ltd?

    Answer Field

    The 1 year returns on the stock has been -26.44%.

    What is the P/E Ratio of Star Imaging and Path Lab Ltd Share?

    Answer Field

    As on Jul 03 2026 01:10 PM the price-to-earnings (PE) ratio for Star Imaging and Path Lab Ltd share is 9.02.

    What is the PB ratio of Star Imaging and Path Lab Ltd Share?

    Answer Field

    As on Jul 03 2026 01:10 PM, the price-to-book (PB) ratio for Star Imaging and Path Lab Ltd share is 66.61.

    How to Buy Star Imaging and Path Lab Ltd Share?

    Answer Field

    You can trade in Star Imaging and Path Lab Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Star Imaging and Path Lab Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Star Imaging and Path Lab Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Star Imaging and Path Lab Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |